---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-008358"
form_type: "8-K"
ticker: "KURA"
cik: "0001422143"
company_name: "Kura Oncology, Inc."
filed_at: "2023-01-13T23:59:59+00:00"
generated_at: "2026-06-20T15:15:49.572109+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kura Oncology CCO Kirsten Flowers resigns; separation agreement provides 6 months salary + 2022 bonus

## Summary
- Kirsten Flowers resigns as Chief Commercial Officer effective Jan 27, 2023.
- Separation agreement provides 6 months base salary and 2022 annual cash bonus (discretionary).
- Flowers agrees to a 6-month non-compete period following separation.
- No successor named; search for replacement is ongoing.

## SEC filing metadata
- accession: 0001193125-23-008358
- form_type: 8-K
- ticker: KURA
- cik: 0001422143
- company_name: Kura Oncology, Inc.
- filed_at: 2023-01-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422143/000119312523008358/0001193125-23-008358-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422143/000119312523008358/d381827d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-008358
- JSON: https://secwatch.observer/filing/0001193125-23-008358.json
- Plain text: https://secwatch.observer/filing/0001193125-23-008358.txt

## Key facts
- Executive change
  Kirsten Flowers resigned as Chief Commercial Officer at Kura Oncology, Inc..
  - Action: resigned
  - Role: Chief Commercial Officer
  source text: On January 10, 2023, Kirsten Flowers notified Kura Oncology, Inc. (the “Company”) of her intention to resign from her position as the Company’s Chief Commercial Officer, effective as of January 27, 2023 (the “Separation Date”), in order to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1422143/000119312523008358/0001193125-23-008358-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.